ONCT logo

Oncternal Therapeutics (ONCT) Non Current Assets

Annual Non Current Assets

$670.00 K
-$691.00 K-50.77%

31 December 2023

ONCT Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Non Current Assets

$154.00 K
-$448.00 K-74.42%

30 September 2024

ONCT Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ONCT Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-50.8%-78.1%
3 y3 years-16.9%-80.2%
5 y5 years+492.9%-84.5%

ONCT Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-50.8%at low-88.8%at low
5 y5 years-50.8%+492.9%-88.8%at low
alltimeall time-91.7%+492.9%-98.3%+51.0%

Oncternal Therapeutics Non Current Assets History

DateAnnualQuarterly
Sept 2024
-
$154.00 K(-74.4%)
June 2024
-
$602.00 K(-5.5%)
Mar 2024
-
$637.00 K(-4.9%)
Dec 2023
$36.06 M(-46.4%)
$670.00 K(-4.7%)
Sept 2023
-
$703.00 K(+0.7%)
June 2023
-
$698.00 K(+91.2%)
Mar 2023
-
$365.00 K(-73.2%)
Dec 2022
$67.29 M(-27.5%)
$1.36 M(-1.4%)
Sept 2022
-
$1.38 M(+152.7%)
June 2022
-
$546.00 K(+29.4%)
Mar 2022
-
$422.00 K(-42.3%)
Dec 2021
$92.85 M(-21.3%)
$732.00 K(-5.7%)
Sept 2021
-
$776.00 K(-5.4%)
June 2021
-
$820.00 K(-15.7%)
Mar 2021
-
$973.00 K(+20.7%)
Dec 2020
$118.00 M(+467.7%)
$806.00 K(-4.6%)
Sept 2020
-
$845.00 K(-4.3%)
June 2020
-
$883.00 K(-26.5%)
Mar 2020
-
$1.20 M(+25.5%)
Dec 2019
$20.79 M(-33.4%)
$957.00 K(-3.7%)
Sept 2019
-
$994.00 K(-3.7%)
June 2019
-
$1.03 M(+911.8%)
Mar 2019
-
$102.00 K(-9.7%)
Dec 2018
$31.21 M(-32.3%)
$113.00 K(-9.6%)
Sept 2018
-
$125.00 K(-8.1%)
June 2018
-
$136.00 K(-8.1%)
Mar 2018
-
$148.00 K(-6.9%)
Dec 2017
$46.08 M(+89.6%)
$159.00 K(-5.9%)
Sept 2017
-
$169.00 K(-6.6%)
June 2017
-
$181.00 K(-5.7%)
Mar 2017
-
$192.00 K(-5.9%)
Dec 2016
$24.30 M(-23.8%)
$204.00 K(-5.1%)
Sept 2016
-
$215.00 K(+52.5%)
June 2016
-
$141.00 K(-3.4%)
Mar 2016
-
$146.00 K(+2.8%)
Dec 2015
$31.89 M(-36.4%)
$142.00 K(-83.5%)
Sept 2015
-
$860.00 K(+50.9%)
June 2015
-
$570.00 K(+29.8%)
Mar 2015
-
$439.00 K(-12.2%)
Dec 2014
$50.15 M(+230.6%)
$500.00 K(-9.9%)
Sept 2014
-
$555.00 K(-18.7%)
June 2014
-
$683.00 K(-7.5%)
Mar 2014
-
$738.00 K(+70.0%)
Dec 2013
$15.17 M
$434.00 K(-38.4%)
DateAnnualQuarterly
Sept 2013
-
$704.00 K(-16.9%)
June 2013
-
$847.00 K(-23.1%)
Mar 2013
-
$1.10 M(+14.9%)
Dec 2012
$56.81 M(-26.1%)
$959.00 K(+16.1%)
Sept 2012
-
$826.00 K(-15.7%)
June 2012
-
$980.00 K(-9.9%)
Mar 2012
-
$1.09 M(-39.8%)
Dec 2011
$76.85 M(+27.3%)
$1.81 M(+15.5%)
Sept 2011
-
$1.57 M(-10.4%)
June 2011
-
$1.75 M(-12.1%)
Mar 2011
-
$1.99 M(-48.9%)
Dec 2010
$60.36 M(+19.1%)
$3.89 M(-7.9%)
Sept 2010
-
$4.22 M(-8.1%)
June 2010
-
$4.59 M(-31.3%)
Mar 2010
-
$6.69 M(-5.0%)
Dec 2009
$50.67 M(-49.3%)
$7.05 M(-5.8%)
Sept 2009
-
$7.48 M(+0.3%)
June 2009
-
$7.45 M(-3.4%)
Mar 2009
-
$7.72 M(-4.5%)
Dec 2008
$100.02 M(-34.3%)
$8.09 M(-3.2%)
Sept 2008
-
$8.35 M(-7.3%)
June 2008
-
$9.01 M(+13.8%)
Mar 2008
-
$7.92 M(+6.1%)
Dec 2007
$152.26 M(+25.1%)
$7.47 M(+8.0%)
Sept 2007
-
$6.91 M(-8.1%)
June 2007
-
$7.53 M(+2.2%)
Mar 2007
-
$7.37 M(-2.5%)
Dec 2006
$121.70 M(+60.1%)
$7.55 M(-0.5%)
Sept 2006
-
$7.59 M(+16.7%)
June 2006
-
$6.51 M(-3.8%)
Mar 2006
-
$6.77 M(-0.6%)
Dec 2005
$76.00 M(+14.9%)
$6.81 M(-5.6%)
Sept 2005
-
$7.21 M(-7.8%)
June 2005
-
$7.83 M(+8.9%)
Mar 2005
-
$7.18 M(+3.7%)
Dec 2004
$66.15 M(+340.3%)
$6.93 M(+270.4%)
Sept 2004
-
$1.87 M(+12.0%)
June 2004
-
$1.67 M(+109.0%)
Mar 2004
-
$799.00 K(-65.0%)
Dec 2003
$15.02 M(+67.6%)
$2.29 M
Dec 2002
$8.97 M(+1.5%)
-
Dec 2001
$8.83 M(+231.2%)
-
Dec 2000
$2.67 M(+73.0%)
-
Dec 1999
$1.54 M
-

FAQ

  • What is Oncternal Therapeutics annual long term assets?
  • What is the all time high annual non current assets for Oncternal Therapeutics?
  • What is Oncternal Therapeutics annual non current assets year-on-year change?
  • What is Oncternal Therapeutics quarterly long term assets?
  • What is the all time high quarterly non current assets for Oncternal Therapeutics?
  • What is Oncternal Therapeutics quarterly non current assets year-on-year change?

What is Oncternal Therapeutics annual long term assets?

The current annual non current assets of ONCT is $670.00 K

What is the all time high annual non current assets for Oncternal Therapeutics?

Oncternal Therapeutics all-time high annual long term assets is $8.09 M

What is Oncternal Therapeutics annual non current assets year-on-year change?

Over the past year, ONCT annual long term assets has changed by -$691.00 K (-50.77%)

What is Oncternal Therapeutics quarterly long term assets?

The current quarterly non current assets of ONCT is $154.00 K

What is the all time high quarterly non current assets for Oncternal Therapeutics?

Oncternal Therapeutics all-time high quarterly long term assets is $9.01 M

What is Oncternal Therapeutics quarterly non current assets year-on-year change?

Over the past year, ONCT quarterly long term assets has changed by -$549.00 K (-78.09%)